Snork, this might help cheer you up. From FiercePharma today:
Sanofi Breaks Ground on $477M vax plant.
SanofiAventis is still testing its new Dengue fever jab, but it's already broken ground on a massive new manufacturing plant in France that will churn out a huge supply of vaccine.
Sanofi is investing $477 million - its most expensive single industrial project - in the new facility north of Lyon. And if it stays on schedule the plant will be ready to start making the new vaccine in 2013. Sanofi CEO Chris Viehbacher says that the new vaccine, once approved, has clear potential for earning more than 1 billion Euros a year.
"It's hard to give a precise estimate, but I wouldn't be investing 350 million Euros if there wasn't a strong chance that this is the biggest vaccine ever," Viehbacher said. "There are 50 million new Dengue fever infections every year."
There's also an interesting side story about an outbreak of Dengue fever this year in and around Rio de Janiero, with 75,000 affected and 12 dead.
"No vaccine is available, leaving officials to house the sick in a tent city while they call in the military to help fumigate areas in an attempt to eradicate the mosquitos that carry the disease."
Make up your own mind.
UNI Price at posting:
28.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)